Home/ Supplements/ Electrolytes/ Yohimbine+ Rauwolscine

Yohimbine+ Rauwolscine

product on market Capsule ALLMAX Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 50% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

Yohimbine and rauwolscine are alpha-2 adrenergic antagonists used to support fat mobilization. Research evidence for these specific ingredients is limited, though they are known to increase norepinephrine levels. These compounds may stimulate lipolysis, but clinical data on their overall efficacy remains sparse.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Yohimbine+ Rauwolscine
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Capsule(s)
Serving Size
60
Servings
Non-Nutrient/Non-Botanical
Product Type
50%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Market median: 4002.0mg (1 products) 21 studies (A:0, B:2)
Rauwolscine
0.5 mg

Other Ingredients

Bovine Gelatin Magnesium Stearate Rice Flour
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Directions: Take 1 capsule daily just prior to exercise. Do not exceed 2 capsules daily.

Warnings & Precautions

Warnings: Do not use if pregnant or nursing. Consult a medical doctor before use if you have been treated for, or diagnose with or have a family history of any medical condition, or if you are using any prescription or over-the-counter drug(s), including blood thinners. Consult your healthcare professional before use if you are taking antidepressants, MAO inhibitors or any other prescription drug.

Discontinue use and consult a medical doctor if you experience unusual symptoms. Discontinue use two weeks prior to surgery. Consult a medical doctor before use if you have been treated for, or diagnose with or have a family history of any medical condition, or if you are using any prescription or over-the-counter drug(s), including blood thinners. Do not use this product if you are at risk or are being treated for high blood pressure, heart, kidney, thyroid or psychiatric disease, anxiety, depression, seizure disorder or stroke. Discontinue use and consult your healthcare professional if dizziness, sleeplessness, tremors, nervousness, headache or heart palpitations occur. Improper use of this product will not improve results, is not advised and may cause adverse reactions listed in the warning. Consult a medical doctor before starting any diet or exercise. Do not use if inner seal is broken.

Keep out of reach of children.

California Warning: Lead is known to the State of California to cause birth defects or reproductive harm. Consuming this product can expose you to more than 0.0000005 g of lead. For more information go to www.P65Warnings.ca.gov. Prop 65

Allergen Warning: Produced in a facility that also handles milk, soy, wheat, egg, peanut, tree nuts, fish, crustacean and shellfish products.

Formulation Notes

Allmax Yohimbine + Rauwolscine (Alpha-Yohimbine) are the pure synthetic versions of Pausinystalia Yohimbine and Rauwolfia serpentina; thousands of times more powerful than the original herbal extracts from which they were isolated.

Most frequently used for rapid fat loss due to its targeted ability to act on store fat, Yohimbine + Rauwolscine limits fat storage and boosts lipolysis; the release of fatty acids within stored fat. Yohimbine has an extremely high affinity for the Alpha 2-adrenoreceptor (Alpha 2-AR). These receptors (primarily in fat cells) control the rate of release of stored fat. As antagonists, Yohimbine & Rauwolscine lock on to Alpha 2 fat cell receptors. Fat storage is deactivated and rapid release of stored fat in initiated. Rauwolscine (or Alpha-Yohimbine), is an extremely rare variation of Yohimbine with a longer half-life and a more powerful Alpha 2-AR affinity. This means you need less of it to create a greater effect; it lasts longer and is the perfect complement to Yohimbine. Yohimbine + Rauwolscine is one of the most effective and efficient fat loss aids. Widely praised for its unique MOA (mechanism of action), Yohimbine + Rauwolscine is radically different than caffeine.

While caffeine is one of the best fat loss analogs out there, those who are looking to "cycle off" caffeine can use Yohimbine + Rauwolscine to affect fat loss in a completely different way.

Product of USA

Supports fat-burning Suppresses appetite

Additional Information

Professional grade supplements

cGMP Registered Facility

Store in a cool, dry place.

Quality Guarantee Purity & Potency Tested

Metadata

Product Details

UPC / SKU6 65553 22353 7
DSLD Entry Date2023-09-25
Product TypeNon-Nutrient/Non-Botanical
FormCapsule
BrandALLMAX
DSLD ID296149
Data Updated2026-04-11
Research

Research Evidence

849
Research Sources
56
Avg Quality
450
Meta Analysis
152
Rct
137
Systematic Review
73
Clinical Trial
11
Regulatory Source
7
Other
7
Guideline
3
Openfda Safety
2
Cochrane Review
2
Observational
A Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2015 PubMed DOI
A Vitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people in mid and late life
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems
Meta Analysis The Cochrane database of systematic reviews 2025 PubMed DOI
A Dietary calcium supplementation for preventing colorectal cancer and adenomatous polyps
Systematic Review The Cochrane database of systematic reviews 2008 PubMed DOI
A Calcium and vitamin D for increasing bone mineral density in premenopausal women
Systematic Review The Cochrane database of systematic reviews 2023 PubMed DOI
A Dietary sodium, sodium-to-potassium ratio, and risk of stroke: A systematic review and nonlinear dose-response meta-analysis
Meta Analysis Clinical nutrition (Edinburgh, Scotland) 2019 PubMed DOI
A The association between circulating magnesium and clinically relevant outcomes in patients with chronic kidney disease: A systematic review and meta-analysis
Meta Analysis Clinical nutrition (Edinburgh, Scotland) 2021 PubMed DOI
A Calcium channel blockers versus other classes of drugs for hypertension
Systematic Review The Cochrane database of systematic reviews 2021 PubMed DOI
View all evidence for Electrolytes →
Compare

Similar Products

View all Electrolytes products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.